Carlsmed, Inc.

NasdaqGS:CARL Stock Report

Market Cap: US$344.8m

Carlsmed Management

Management criteria checks 3/4

Carlsmed's CEO is Mike Cordonnier, appointed in Jun 2018, has a tenure of 7.33 years. total yearly compensation is $520.03K, comprised of 69.6% salary and 30.4% bonuses, including company stock and options. directly owns 4.66% of the company’s shares, worth $16.07M. The average tenure of the management team and the board of directors is 2.2 years and 4.8 years respectively.

Key information

Mike Cordonnier

Chief executive officer

US$520.0k

Total compensation

CEO salary percentage69.60%
CEO tenure7.3yrs
CEO ownership4.7%
Management average tenure2.2yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

Carlsmed: Spine Play Does Not Have My Backing Yet

Jul 24

CEO Compensation Analysis

How has Mike Cordonnier's remuneration changed compared to Carlsmed's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2025n/an/a

-US$26m

Mar 31 2025n/an/a

-US$26m

Dec 31 2024US$520kUS$362k

-US$25m

Compensation vs Market: Mike's total compensation ($USD520.03K) is below average for companies of similar size in the US market ($USD2.32M).

Compensation vs Earnings: Insufficient data to compare Mike's compensation with company performance.


CEO

Mike Cordonnier (49 yo)

7.3yrs
Tenure
US$520,034
Compensation

Mr. Michael John Cordonnier, also known as Mike, is Co-Founder, Chief Executive Officer, President and Chairman at Carlsmed, Inc. since June 2018 and served as its Treasurer from November 2022 to August 20...


Leadership Team

NamePositionTenureCompensationOwnership
Michael Cordonnier
Co-Founder7.3yrsUS$520.03k4.66%
$ 16.1m
Leonard Greenstein
CFO & Treasurer2.2yrsUS$488.39k0.54%
$ 1.9m
William Durall
Chief Commercial Officerless than a yearUS$599.62kno data
Niall Casey
Co-Founder7.3yrsno data3.53%
$ 12.2m
Shariq Hussain
Chief Technology Officerno datano datano data
Jenifer Kamocsay
Chief Legal Officer & Secretaryless than a yearno datano data
Jodi Coe
Senior Vice President of People & Cultureno datano datano data
Sharon Schulzki
Chief Clinical & Market Access Officerno datano datano data
Jeff Bertolini
Senior Vice President of Operational Excellenceno datano datano data
2.2yrs
Average Tenure
49yo
Average Age

Experienced Management: CARL's management team is considered experienced (2.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Michael Cordonnier
Co-Founder7.3yrsUS$520.03k4.66%
$ 16.1m
Niall Casey
Co-Founder7.3yrsno data3.53%
$ 12.2m
Jonathan Root
Independent Director4.8yrsno data1.76%
$ 6.1m
Philip Young
Independent Director4.8yrsno data0.33%
$ 1.2m
Kevin O'Boyle
Independent Director1.1yrsUS$296.09kno data
Kevin Sidow
Independent Director4.8yrsUS$99.55k0.16%
$ 547.8k
Robert Mittendorff
Independent Director3.5yrsno datano data
4.8yrs
Average Tenure
65yo
Average Age

Experienced Board: CARL's board of directors are considered experienced (4.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/06 09:09
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Carlsmed, Inc. is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Travis SteedBofA Global Research
Travis SteedBofA Global Research
Michael GormanBTIG